Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells

被引:55
作者
Pueyo, ME [1 ]
Chen, Y [1 ]
D'Angelo, G [1 ]
Michel, JB [1 ]
机构
[1] Fac Med Xavier Bichat, INSERM, U460, F-75018 Paris, France
关键词
D O I
10.1006/excr.1997.3864
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vascular endothelial growth factor (VEGF) is an endothelial cell mitogen which stimulates angiogenesis. VEGF is regulated by multiple factors such as hypoxia, phorbol esters, and growth factors. However, data concerning the expression of VEGF in the different vascular cell types and its regulation by cAMP are not available. In the present study, we have investigated the effect of adenylate cyclase activation on VEGF mRNA expression in rat vascular cells in primary culture. Basal VEGF expression is greater in smooth muscle cells than in endothelial cells and fibroblasts. A 4-h treatment with forskolin (10(-5) M) induced a 2-fold stimulation of VEGF mRNA expression in smooth muscle cells and fibroblasts, but, in contrast, did not affect VEGF expression in endothelial cells. In smooth muscle cells, a pharmacologically induced increase in intracellular cAMP levels using iloprost or isoprenaline led to a rise in VEGF mRNA expression comparable to that induced by forskolin. Adenosine, which increases cAMP levels in smooth muscle cells, also increases VEGF expression. Moreover, the 2.2-fold stimulation of VEGF expression by adenosine was enhanced following a cotreatment with cobalt chloride (a hypoxia miming agent). The observed additive effect (4.3-fold increase) suggests that these two factors, hypoxia and adenosine, regulate VEGF mRNA expression in smooth muscle cells by independent mechanisms. (C) 1998 Academic Press.
引用
收藏
页码:354 / 358
页数:5
相关论文
共 27 条
[1]   SELECTIVE ISOLATION OF RAT AORTIC-WALL LAYERS AND THEIR CELL-TYPES IN CULTURE - APPLICATION TO CONVERTING-ENZYME ACTIVITY MEASUREMENT [J].
BATTLE, T ;
ARNAL, JF ;
CHALLAH, M ;
MICHEL, JB .
TISSUE & CELL, 1994, 26 (06) :943-955
[2]   THE CARDIAC EFFECTS OF ADENOSINE [J].
BELARDINELLI, L ;
LINDEN, J ;
BERNE, RM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1989, 32 (01) :73-97
[3]  
BELLARDINELLI L, 1993, DRUG DEVELOP RES, V28, P263
[4]  
CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317
[5]  
DAngelo G, 1997, J CELL BIOCHEM, V67, P353, DOI 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.0.CO
[6]  
2-V
[7]  
DUIJVESTIJN AM, 1992, LAB INVEST, V66, P459
[8]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[9]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR IN PIG CEREBRAL MICROVASCULAR ENDOTHELIAL-CELLS AND ITS UP-REGULATION BY ADENOSINE [J].
FISCHER, S ;
SHARMA, HS ;
KARLICZEK, GF ;
SCHAPER, W .
MOLECULAR BRAIN RESEARCH, 1995, 28 (01) :141-148
[10]  
GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355